Inequitable Conduct Still In Play In Crestor Suit
A magistrate judge has recommended that a court hold off on ruling whether AstraZeneca PLC procured a patent for cholesterol drug Crestor through inequitable conduct, potentially sending the issue to trial...To view the full article, register now.
Already a subscriber? Click here to view full article